Literature DB >> 30572157

Transcriptome analysis of silver nanoparticles treated Staphylococcus aureus reveals potential targets for biofilm inhibition.

Nimisha Singh1, Jyutika Rajwade2, K M Paknikar3.   

Abstract

The biofilms of Staphylococcus aureus on the implanted materials and chronic wounds are life-threatening and are a substantial financial burden on the healthcare system. Silver nanoparticles (SNP), known for their multi-level physiological effects in planktonic cells could be a promising agent in the treatment of biofilm-related infections also. To gain insight into the effects of SNP on various physiological processes in biofilms we studied the transcriptome of Staphylococcus aureus ATCC 29213. To distinguish between 'nanoparticles-specific' and 'ion-specific' effect of silver, we performed a comparative analysis of the functional genes in response to Ag+. As compared to untreated biofilms, 21% (i.e. 629 genes) and 28.5% (i. e. 830 genes) of the total functional coding genes were differentially regulated upon exposure to SNP and Ag+. Genes encoding capsular polysaccharides, intercellular adhesion, virulence were downregulated in SNP and Ag+ treated biofilms. Genes involved in carbohydrate, protein metabolism including DNA and RNA synthesis, oxidative stress etc. were differentially expressed. Further, activation of efflux pumps and multidrug export proteins was observed, which clearly indicates the presence of metal stress resistance determinants in S. aureus. Silver blocked the integration of mobile genetic elements in S. aureus genome. Our study points out quorum sensing and virulence determinants as possible targets for inhibition of biofilms possibly with/without existing antibiotics. However, further studies on these aspects are warranted. Scanning electron microscopy (SEM) and confocal microscopy revealed changes in biofilm morphology, architecture and thickness in presence of silver nanoparticles and ionic silver, substantiating the transcriptome data.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ag ions; Biofilms; Differential expression of genes; RNA-seq analysis; Silver nanoparticles (SNP); Transcriptome

Mesh:

Substances:

Year:  2018        PMID: 30572157     DOI: 10.1016/j.colsurfb.2018.12.032

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  Novel silver metformin nano-structure to impede virulence of Staphylococcus aureus.

Authors:  Hisham A Abbas; Ghada H Shaker; Farag M Mosallam; Salwa E Gomaa
Journal:  AMB Express       Date:  2022-06-30       Impact factor: 4.126

2.  New dynamic microreactor system to mimic biofilm formation and test anti-biofilm activity of nanoparticles.

Authors:  Natalia Bourguignon; Vivek Kamat; Maximiliano Perez; Kalai Mathee; Betiana Lerner; Shekhar Bhansali
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-24       Impact factor: 4.813

3.  Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii.

Authors:  Helal F Hetta; Israa M S Al-Kadmy; Saba Saadoon Khazaal; Suhad Abbas; Ahmed Suhail; Mohamed A El-Mokhtar; Noura H Abd Ellah; Esraa A Ahmed; Rasha B Abd-Ellatief; Eman A El-Masry; Gaber El-Saber Batiha; Azza A Elkady; Nahed A Mohamed; Abdelazeem M Algammal
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

4.  Comparative Transcriptome Analysis Reveals Differentially Expressed Genes Related to Antimicrobial Properties of Lysostaphin in Staphylococcus aureus.

Authors:  Xianghe Yan; Yanping Xie; Charles Li; David M Donovan; Andrew Gehring; Peter Irwin; Yiping He
Journal:  Antibiotics (Basel)       Date:  2022-01-18

5.  The Antibacterial Effect of Silver Nanoparticles on Staphylococcus epidermidis Strains with Different Biofilm-Forming Ability.

Authors:  Denis Swolana; Małgorzata Kępa; Danuta Idzik; Arkadiusz Dziedzic; Agata Kabała-Dzik; Tomasz J Wąsik; Robert D Wojtyczka
Journal:  Nanomaterials (Basel)       Date:  2020-05-25       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.